BNTC $27.3125, page-3

"American investors are probably going to flock to this stock. The company brings an extensive in-house pipeline of big market potential drugs, plus a slew of licensed drug indications, and strong government grant support."

I already did flock to this stock. Why? Because I saw the Mechanism of Action (MOA) and jumped on board at 57 cents American! All we need is some efficacy, and hot diggety, this will be the next talked-about biotech, IMO. Glad I'm in early!